by The vaginal pessary market consists of different types of products that are inserted into the vagina to support pelvic organs. Some of the common types used include ring pessary, shell pessary, and Gellhorn pessary. Pessaries help provide relief from symptoms like pressure or discomfort caused due to pelvic organ prolapse. They are generally made of silicone or latex rubber and are comfortable to use on a daily basis. Vaginal pessaries offer a non-surgical treatment option for pelvic organ prolapse and stress urinary incontinence.
The Global vaginal pessary market is estimated to be valued at US$ 411.68 Mn in 2024 and is expected to exhibit a CAGR of 8.3% over the forecast period of 2024 to 2031.
Key Takeaways
Key players operating in the vaginal pessary market are Arakawa Chemical Industries, Eastman Chemical Company, Exxon Mobil Corporation, Ltd., Kolon Industries, Inc., Lesco Chemical Limited, Zeon Corporation, Seacon Corporation, Neville Chemical Company, Total Cray Valley, and Anglxxon Chemical Co., Ltd. The market players are focusing on new product launches and geographical expansion strategies to gain market share.
Some of the key opportunities in the vaginal pessary market include increasing awareness about non-surgical treatment options and favorable reimbursement policies for pelvic organ prolapse treatments. The global expansion of major players into developing regions will further propel the market growth over the forecast period.
The growing geriatric population worldwide is more prone to developing pelvic organ prolapse due to aging factors. This has significantly increased the incidences of pelvic organ prolapse especially in developing regions of Asia Pacific and Latin America. The market players are focusing on expanding their distribution networks in these emerging markets to tap into new growth opportunities.
Market drivers
The rising incidences of pelvic organ prolapse due to increasing life expectancy and obesity rates is a major market driver. According to the International Continence Society, pelvic organ prolapse affects nearly 50% of middle-aged women and geriatric women. Pessaries offer an effective treatment option to improve quality of life for women suffering from this medical condition.
PEST Analysis
Political: Healthcare reforms in various countries are providing impetus to usage of pessaries for issues related to prolapse and incontinence. Government initiatives to spread awareness regarding women’s health issues are positively influencing the market growth.
Economic: Rising healthcare expenditure along with high disposable incomes among women in developing countries is facilitating market growth. However, unfavorable changes in reimbursement policies can hamper the demand for pessaries.
Social: Increasing cases of pelvic organ prolapse and urinary incontinence among women due to various reasons like childbirth injuries, obesity, chronic cough, etc. is a key factor supporting the market growth. Also, rising awareness about women’s health issues is positively impacting the adoption of pessaries.
Technological: Technological advancements in materials used for manufacturing pessaries are leading to development of improved products with enhanced comfort, durability and effectiveness. In addition, 3D printing technology is enabling customization of pessaries as per the patient’s anatomy.
Market concentration
The Vaginal Pessary Market Size in terms of value is highly concentrated in North America and Western Europe. This can be attributed to the prevalence of pelvic organ prolapse and incontinence issues among women along with growing awareness about treatment options in these regions. According to estimates, North America held around 30% share of the overall market in 2024 followed by Western Europe.
Fastest growing region
Asia Pacific is expected to witness the fastest growth in the vaginal pessary market during the forecast period. This growth can be credited to factors like rising healthcare spends, increasing women population, growing awareness about women’s health issues. Moreover, improving accessibility of treatment along with initiatives by market players to strengthen distribution networks in emerging countries like China and India are further supporting the market expansion in Asia Pacific. The region is estimated to register a CAGR of over 10% between 2024 to 2031.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
